News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
338,654 Results
Type
Article (19284)
Company Profile (94)
Press Release (319276)
Multimedia
Podcasts (24)
Webinars (5)
Section
Business (89284)
Career Advice (1329)
Deals (17519)
Drug Delivery (62)
Drug Development (61299)
Employer Resources (61)
FDA (9122)
Job Trends (7522)
News (174499)
Policy (15246)
Tag
Academia (1218)
Academic (1)
Accelerated approval (4)
Adcomms (15)
Allergies (68)
Alliances (17855)
ALS (73)
Alzheimer's disease (953)
Antibody-drug conjugate (ADC) (112)
Approvals (9171)
Artificial intelligence (141)
Autoimmune disease (16)
Automation (8)
Bankruptcy (139)
Best Places to Work (6369)
BIOSECURE Act (8)
Biosimilars (68)
Biotechnology (61)
Bladder cancer (73)
Brain cancer (28)
Breast cancer (322)
Cancer (2160)
Cardiovascular disease (153)
Career advice (1048)
Career pathing (16)
CAR-T (114)
CDC (7)
Cell therapy (303)
Cervical cancer (17)
Clinical research (51983)
Collaboration (503)
Compensation (259)
Complete response letters (9)
COVID-19 (2224)
CRISPR (30)
C-suite (98)
Cystic fibrosis (72)
Data (2381)
Denatured (1)
Depression (32)
Diabetes (265)
Diagnostics (3407)
Digital health (9)
Diversity (1)
Diversity, equity & inclusion (8)
Drug discovery (79)
Drug pricing (56)
Drug shortages (23)
Duchenne muscular dystrophy (79)
Earnings (53951)
Editorial (21)
Employer branding (11)
Employer resources (52)
Events (54470)
Executive appointments (275)
FDA (10241)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (1)
Frontotemporal dementia (4)
Funding (516)
Gene editing (68)
Generative AI (9)
Gene therapy (225)
GLP-1 (686)
Government (2412)
Grass and pollen (4)
Guidances (164)
Healthcare (9670)
Huntington's disease (18)
IgA nephropathy (29)
Immunology and inflammation (105)
Immuno-oncology (3)
Indications (30)
Infectious disease (2314)
Inflammatory bowel disease (103)
Inflation Reduction Act (5)
Influenza (40)
Intellectual property (72)
Interviews (244)
IPO (10208)
IRA (19)
Job creations (1455)
Job search strategy (908)
Kidney cancer (14)
Labor market (32)
Layoffs (250)
Leadership (14)
Legal (2483)
Liver cancer (53)
Lung cancer (321)
Lymphoma (164)
Machine learning (2)
Management (17)
Manufacturing (178)
MASH (74)
Medical device (6395)
Medtech (6395)
Mergers & acquisitions (7720)
Metabolic disorders (666)
Multiple sclerosis (78)
NASH (17)
Neurodegenerative disease (79)
Neuropsychiatric disorders (21)
Neuroscience (1422)
NextGen: Class of 2025 (2662)
Non-profit (1852)
Now hiring (13)
Obesity (360)
Opinion (107)
Ovarian cancer (75)
Pain (74)
Pancreatic cancer (81)
Parkinson's disease (142)
Partnered (11)
Patents (139)
Patient recruitment (98)
Peanut (37)
People (15650)
Pharmaceutical (28)
Pharmacy benefit managers (4)
Phase I (14763)
Phase II (25638)
Phase III (16716)
Pipeline (1342)
Policy (67)
Postmarket research (1587)
Preclinical (4954)
Press Release (30)
Prostate cancer (107)
Psychedelics (23)
Radiopharmaceuticals (157)
Rare diseases (293)
Real estate (1743)
Recruiting (29)
Regulatory (11955)
Reports (35)
Research institute (1161)
Resumes & cover letters (257)
Rett syndrome (9)
RNA editing (3)
RSV (28)
Schizophrenia (64)
Series A (74)
Series B (57)
Service/supplier (6)
Sickle cell disease (45)
Special edition (17)
Spinal muscular atrophy (133)
Sponsored (21)
Startups (1344)
State (2)
Stomach cancer (13)
Supply chain (36)
Tariffs (29)
The Weekly (23)
Vaccines (525)
Venture capitalists (19)
Weight loss (232)
Women's health (20)
Worklife (11)
Date
Today (97)
Last 7 days (330)
Last 30 days (1645)
Last 365 days (20719)
2025 (10048)
2024 (22022)
2023 (24445)
2022 (29984)
2021 (32062)
2020 (30534)
2019 (22702)
2018 (17293)
2017 (17516)
2016 (15308)
2015 (18682)
2014 (13373)
2013 (9816)
2012 (10616)
2011 (11095)
2010 (9732)
Location
Africa (409)
Alabama (33)
Alaska (1)
Arizona (70)
Arkansas (4)
Asia (21985)
Australia (3939)
California (4540)
Canada (1431)
China (478)
Colorado (172)
Connecticut (215)
Delaware (127)
Europe (48916)
Florida (606)
Georgia (153)
Idaho (26)
Illinois (294)
India (14)
Indiana (213)
Iowa (10)
Japan (157)
Kansas (48)
Kentucky (23)
Louisiana (8)
Maine (37)
Maryland (582)
Massachusetts (3323)
Michigan (108)
Minnesota (209)
Mississippi (3)
Missouri (46)
Montana (14)
Nebraska (7)
Nevada (49)
New Hampshire (39)
New Jersey (1354)
New Mexico (4)
New York (1354)
North Carolina (539)
North Dakota (3)
Northern California (2008)
Ohio (116)
Oregon (17)
Pennsylvania (917)
Puerto Rico (15)
Rhode Island (14)
South America (569)
South Carolina (11)
Southern California (1788)
Tennessee (42)
Texas (666)
United States (16202)
Utah (124)
Virginia (89)
Washington D.C. (36)
Washington State (381)
West Virginia (1)
Wisconsin (33)
338,654 Results for "2".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
China’s HER2-Targeted ADC Trastuzumab Rezetecan Gains NMPA Approval for HER2-Mutant NSCLC
May 29, 2025
·
2 min read
Press Releases
Solventum Launches Preassembled, See-through VH2O2 Test Pack for Low-temp Medical Instrument Sterilization
June 10, 2025
·
7 min read
Press Releases
Milestone Scientific Reports Revenue of $2.2 Million and Provides Business Update for the First Quarter of 2025
May 15, 2025
·
7 min read
Press Releases
Ensysce Biosciences, Inc. Announces Exercise of Warrants for $2.2 Million Gross Proceeds
April 23, 2025
·
4 min read
Mergers & acquisitions
BMS Buys Abecma Partner 2seventy for $286M, Ending Cost Sharing Agreement
Abecma made $406 million in 2024, of which BMS paid $43 million to 2seventy bio as part of their profit-sharing agreement.
March 11, 2025
·
3 min read
·
Tristan Manalac
Press Releases
Zealand Pharma announces first participant enrolled in Phase 2b ZUPREME-2 trial of petrelintide in people with overweight or obesity and type 2 diabetes
April 24, 2025
·
8 min read
Press Releases
Ensysce Biosciences, Inc. Announces Closing of Exercise of Warrants for $2.2 Million Gross Proceeds
April 25, 2025
·
4 min read
Press Releases
Addex Regains Rights to Phase 2 mGlu2 PAM Asset ADX71149
April 17, 2025
·
3 min read
Press Releases
Myomo Launches the MyoPro® 2x
April 30, 2025
·
3 min read
Press Releases
Curevo Enrolls First Participants in Phase 2 Extension Trial
June 2, 2025
·
2 min read
1 of 33,866
Next
